Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28988065 | 0.98 | LMNA (0.35) | LMNAALOX15 | |
| SCHEMBL18367787 | 0.87 | LMNA (0.32) | LMNA | |
| SCHEMBL7563105 | 0.82 | ALOX15 (0.34) | LMNAALOX15 | |
| SCHEMBL7654777 | 0.80 | LMNA (0.36) | LMNA | |
| SCHEMBL49693 | 0.79 | LMNA (0.39) | LMNA | |
| SCHEMBL686392 | 0.78 | ALOX15 (0.32) | ALOX15 | |
| Ammonia Solution, Strong SCHEMBL5681835 | 0.77 | LMNA (0.38) | LMNA | |
| SCHEMBL56162 | 0.77 | LMNA (0.38) | LMNA | |
| SCHEMBL29534835 | 0.77 | LMNA (0.38) | LMNAALOX15 | |
| SCHEMBL4624700 | 0.77 | LMNA (0.38) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115105868-A | Organic silicon defoaming agent and preparation method thereof | 佛山市南海大田化学有限公司 | 2022-09-27 | — | — | CN | claimed |
| US-20130101999-A1 | MULTI-LEG LUMINESCENT NANOPARTICLES, MULTI-LEG LUMINESCENT NANOPARTICLE COMPOUNDS AND VARIOUS APPLICATIONS | NANOAXIS, LLC (US) | 2013-04-25 | — | — | US | claimed |
| US-20130035258-A1 | LUMINESCENT TETRAPODS DOTS AND VARIOUS APPLICATIONS | NANOAXIS, LLC (US) | 2013-02-07 | — | — | US | claimed |
| US-7917298-B1 | Nanocrystal taggants | NANOSYS, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20100028402-A1 | NANOPARTICLE-BASED ANTICOAGULANT | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2010-02-04 | — | — | US | claimed |
| WO-2008063157-A2 | A NANOPARTICLE-BASED ANTICOAGULANT | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-05-29 | — | — | WO | claimed |
| US-6699723-B1 | CAPABLE OF LUMINESCENCE AND/OR ABSORPTION AND/OR SCATTERING OR DIFFRACTION WHEN EXCITED BY A RADIATION OR PARTICLE BEAM;USED FOR ELECTRON MICROSCOPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-03-02 | — | — | US | claimed |
| US-6423551-B1 | CORE WITH SHELL OVERCOATING AND LINKING AGENT FOR AFFINITY MOLECULE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-07-23 | — | — | US | claimed |
| US-4785039-A | PROTECTIVE COATING FOR GLASS FIBER PACKAGES | OWENS-CORNING FIBERGLASS CORPORATION (US) | 1988-11-15 | — | — | US | claimed |
| US-4636437-A | PROTECTIVE FILMS | OWENS-CORNING FIBERGLAS CORPORATION (US) | 1987-01-13 | — | — | US | claimed |
| EP-0199763-A1 | GLASS FIBER SIZE AND IMPREGNANT COMPOSITIONS | OWENS-CORNING FIBERGLAS CORPORATION (US) | 1986-11-05 | — | — | EP | claimed |
| WO-1986002920-A1 | GLASS FIBER SIZE AND IMPREGNANT COMPOSITIONS | OWENS-CORNING FIBERGLAS CORPORATION (US) | 1986-05-22 | — | — | WO | claimed |
| US-20240142445-A1 | OPTICAL ANALYTE DETECTION SYSTEMS AND METHODS OF USE | GENALYTE INC (US) | 2024-05-02 | — | — | US | disclosed |
| EP-3733866-B1 | OPTICAL ANALYTE DETECTION SYSTEMS AND METHODS OF USE | GENALYTE INC (US) | 2023-11-15 | — | — | EP | disclosed |
| EP-3907506-A1 | OPTICAL ANALYTE DETECTION SYSTEMS WITH MAGNETIC ENHANCEMENT AND METHODS OF THEIR USE | The Board of Trustees of the University of Illinois (US) | 2021-11-10 | — | — | EP | disclosed |
| EP-2825885-B1 | OPTICAL ANALYTE DETECTION SYSTEMS WITH MAGNETIC ENHANCEMENT | UNIV ILLINOIS (US) | 2021-05-12 | — | — | EP | disclosed |
| US-6177030-B1 | OVERCOATING PHOSPHOR WITH METAL OXIDE AND COUPLING AGENT | KONICA CORPORATION (JP) | 2001-01-23 | — | — | US | disclosed |
| US-5990479-A | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-11-23 | — | — | US | disclosed |
| US-5272224-A | Polyurethane based adhesion composition and method | ADCO PRODUCTS, INC. (US) | 1993-12-21 | — | — | US | disclosed |
| EP-0459304-A2 | A one component sealant composition | ADCO PRODUCTS, INC. (US) | 1991-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028402-A1 | NANOPARTICLE-BASED ANTICOAGULANT | SERPINC1, F2, ADAMTS13 | LMNA 615/4885ALOX15 4009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.